Curus Invests in Wellon


Investment firm Curus has completed an investment in the health startup Wellon. Wellon offers a service where consumers can be tested for the need for specific vitamins, minerals, and other supplements. After analysis, a customised supplement package is tailored and delivered to the customer every month in convenient dosage pouches.

There is a clear trend where an increasing number of people are seeking customised solutions for their supplements, especially in light of new supplements constantly launching in the market. For vitamins and supplements to truly be effective, they need to be tailored to an individual’s body and lifestyle. Wellon has addressed this by ensuring their nutritional recommendations are personalised and easy to follow, and by only using supplements from well-known and proven brands. Additionally, they have their own machinery for dose dispensing, further strengthening their market position.

“We are entering Wellon with great enthusiasm. It is evident that the area of supplements is garnering increased interest from the general public, and we look forward to being a part of this journey with Wellon,” says Erik Olsson Nyrén, Investment Manager at Curus.

In the USA, there are several major players similar to Wellon where many consumers are transitioning to customised solutions. Wellon aims to launch its service in Europe and become one of the major players in the sector.

Ylva Pagmén, CEO of Wellon, comments: “The company is going from strength to strength, and we see constant growth. Nearly 60% of the population regularly take supplements, but many are unsure if they really need them or feel the frustration of managing numerous containers and products. Our service addresses both these issues.”

Jacob Versteegh, CEO of Bonver Group, one of the major shareholders in Wellon, is also positive about Curus’s investment: “We are delighted that Curus has chosen to invest in Wellon. It underlines the potential and value we see in the company and its service.”


For more information
Erik Olsson Nyrén, Investment Manager Curus,
[email protected], +46 70 837 73 54
Johan Bloom, CEO Curus,
[email protected], +46 733 648 490
Ylva Pagmén, CEO Wellon,
[email protected], +46 70 476 85 22
Jacob Versteegh, CEO Bonver Group,
[email protected], +46 70 976 08 60


About Curus
Curus is an investment firm that invests within the Nordic region with a special focus on digital health and healthcare. Curus has the capacity to make both minority and majority investments and can provide both capital, industry experience, networking, and marketing to their portfolio companies. Curus has investments in 5 majority-owned companies and minority stakes in 22 growth companies. For more information, visit

About Wellon
Wellon is a health startup focused on customised supplements. By offering consumers tests and personalised recommendations, the company aims to make it easier and more effective for individuals to achieve optimal health. For more information, visit

Related News

Curus is main partner at Framtidens Hälso & Sjukvård (the Future of Health & Healthcare)

On January 25-26, 2023, Kistamässan will turn into one of Sweden's most important gathering points for decision-makers in healthcare. Three trade fairs will gather under…



Do you want to receive news about the future of health and healthcare?

Receive free newsletters on digital health such as trends, research and investments.